Vicki Plaks
Senior Director, Scientific Head of Cell Therapy Oncology, Translational Research Johnson & Johnson
Dr. Vicki Plaks, LLB, PhD, is Senior Scientific Director and Head of Cell Therapy, Oncology Translational Research at Johnson & Johnson, where she leads translational research to advance CAR-T cell therapy programs. She has extensive experience bridging scientific discovery with clinical application in oncology. Previously, Dr. Plaks held research and translational positions in biopharma and academic sectors, contributing to biomarker and mechanism-focused immuno-oncology research. Her work supports efforts to deepen our understanding of mechanisms of efficacy and safety underlying clinical outcomes associated with CAR-T cell therapy and immuno-oncology therapies and improve therapeutic strategies for patients with cancer.
Seminars
- Highlighting evolving modality innovations and industry shifts to demonstrate how rapid scientific and technological progress is enhancing treatment accessibility and reshaping the cell therapy landscape
- Aligning clinical development, scalability and patient access strategies to accelerate commercialization pathways across advanced cell therapy modalities
- Discussing post-approval reimbursement policies and strategies to ensure long-term commercial success
- Predicting cell therapy evolution through 2026 and beyond to provide strategic and commercial foresight
- Highlighting biomarker data associated with clinical safety, efficacy from Prizlo-cel anti-CD19/CD20 CAR-T therapy
- Showcasing early efficacy results to illustrate how dual targeting improves clinical response
- Utilizing early success to inform next steps towards expanded clinical use
